Pharmaceutical company Roche announced the expansion of its digital pathology open environment by integrating more than 20 advanced artificial intelligence algorithms from eight new collaborators. The ...
Digital Pathology is an ever-expanding ecosystem of bioinformatics and whole-slide scanning solutions that are helping to revolutionize workflows within medical diagnostics. These systems offer ...
LigoLab, a leading provider of enterprise laboratory information system (LIS) software and fully integrated laboratory revenue cycle management (lab RCM) solutions, and PathPresenter, a global leader ...
Digital pathology developer Proscia is launching an artificial intelligence toolkit for life science researchers alongside a program that translates biopsy slide images into quantitative data for ...
Antibody-drug conjugates (ADCs) are a novel class of cancer therapeutics comprised of a linker-payload conjugated to a selective monoclonal antibody targeting a tumor-associated antigen (TAA) to ...
PARIS--(BUSINESS WIRE)--Owkin, the first end-to-end AI-biotech that uses cutting-edge AI to unlock precision drug discovery, development, and diagnostics, has launched its latest report, State of the ...
OREM, UTAH, UNITED STATES, January 24, 2023 / EINPresswire.com / -- Techcyte, the developers of the Clinical Pathology AI Platform, added powerful platform workflow enhancements (profiles and post ...
The vision for automated diagnosis of computer-analyzed biopsy images is one that has the potential to drive enormous advances in pathology. The idea of being able to have a computer supplement the ...
Grand Blanc, Mich.-based McLaren Health Care fully transitioned to digital pathology services July 1. The system’s central core laboratory and 12 hospital-based laboratories now scan glass pathology ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pramana, Inc., will showcase its suite of transformative solutions enabling Digital Pathology 2.0 at the USCAP annual conference in Baltimore, MD, March 25-28, 2024, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results